Eyegate Pharmaceuticals Shares Outstanding 2013-2020 | EYEG

Eyegate Pharmaceuticals shares outstanding from 2013 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Eyegate Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2020 5
2019 3
2018 2
2017 1
2016 1
2015 0
2014 0
2013 0
2012 0
Eyegate Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 5
2020-09-30 5
2020-06-30 5
2020-03-31 5
2019-12-31 3
2019-09-30 3
2019-06-30 3
2019-03-31 5
2018-12-31 2
2018-09-30 3
2018-06-30 3
2018-03-31 1
2017-12-31 1
2017-09-30 1
2017-06-30 1
2017-03-31 1
2016-12-31 1
2016-09-30 1
2016-06-30 1
2016-03-31 1
2015-12-31 0
2015-09-30 0
2015-06-30 0
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.030B $0.000B
EyeGate Pharmaceuticals, Inc. is a pharmaceutical company which is engaged in developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The company's technology consists of EyeGate(R) II Delivery System. Its product pipeline includes EGP-437 which is in different clinical stage. EyeGate Pharmaceuticals, Inc. is based in WALTHAM, MA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.586B 42.97
Takeda Pharmaceutical (TAK) Japan $54.278B 9.94
Astellas Pharma (ALPMY) Japan $28.276B 17.46
Eisai (ESALY) Japan $19.802B 21.96
Catalent (CTLT) United States $18.893B 49.99
Grifols, S.A (GRFS) Spain $12.562B 14.62
Jazz Pharmaceuticals (JAZZ) Ireland $9.485B 15.84
United Therapeutics (UTHR) United States $8.983B 17.45
Neurocrine Biosciences (NBIX) United States $8.981B 20.70
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.573B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $7.056B 0.00
Evotec AG (EVTCY) Germany $6.591B 445.06
Orion OYJ (ORINY) Finland $5.789B 20.11
Ionis Pharmaceuticals (IONS) United States $5.780B 0.00
Sage Therapeutics (SAGE) United States $4.408B 0.00
Hypermarcas (HYPMY) Brazil $3.913B 15.44
Turning Point Therapeutics (TPTX) United States $3.783B 0.00
Nektar Therapeutics (NKTR) United States $3.529B 0.00
PTC Therapeutics (PTCT) United States $3.389B 0.00
ChemoCentryx (CCXI) United States $3.288B 0.00
Relay Therapeutics (RLAY) United States $3.049B 0.00
Cronos Group (CRON) Canada $2.933B 0.00
Pacira BioSciences (PCRX) United States $2.910B 49.14
Tilray (TLRY) Canada $2.910B 0.00
Organogenesis Holdings (ORGO) United States $2.892B 173.85
Revolution Medicines (RVMD) United States $2.869B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.848B 17.64
Corcept Therapeutics (CORT) United States $2.691B 26.99
Xencor (XNCR) United States $2.589B 0.00
USANA Health Sciences (USNA) United States $2.092B 17.31
BioCryst Pharmaceuticals (BCRX) United States $2.015B 0.00
FibroGen (FGEN) United States $1.777B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.769B 11.35
Ironwood Pharmaceuticals (IRWD) United States $1.745B 13.72
Heron Therapeutics (HRTX) United States $1.620B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.606B 0.00
ImmunoGen (IMGN) United States $1.538B 0.00
Translate Bio (TBIO) United States $1.480B 0.00
AlloVir (ALVR) United States $1.471B 0.00
Sundial Growers (SNDL) Canada $1.415B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.402B 0.00
Aclaris Therapeutics (ACRS) United States $1.400B 0.00
Endo (ENDP) Ireland $1.395B 2.11
Indivior (INVVY) United States $1.371B 0.00
Ocular Therapeutix (OCUL) United States $1.229B 0.00
Zogenix (ZGNX) United States $1.096B 0.00
Trillium Therapeutics (TRIL) Canada $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.044B 0.00
4D Molecular Therapeutics (FDMT) $0.968B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.926B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Ardelyx (ARDX) United States $0.855B 0.00
Aerie Pharmaceuticals (AERI) United States $0.841B 0.00
Bioventus (BVS) United States $0.839B 0.00
Collegium Pharmaceutical (COLL) United States $0.826B 30.87
Esperion Therapeutics (ESPR) United States $0.756B 0.00
Karyopharm Therapeutics (KPTI) United States $0.727B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.679B 0.00
Harpoon Therapeutics (HARP) United States $0.657B 0.00
Rafael Holdings (RFL) United States $0.656B 0.00
Chinook Therapeutics (KDNY) United States $0.646B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.643B 0.00
VAXART, INC (VXRT) United States $0.639B 0.00
KalVista Pharmaceuticals (KALV) United States $0.613B 0.00
Sigilon Therapeutics (SGTX) $0.580B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.572B 0.00
Nanobiotix S.A (NBTX) France $0.572B 0.00
Siga Technologies (SIGA) United States $0.549B 9.17
Marinus Pharmaceuticals (MRNS) United States $0.526B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.500B 0.00
Molecular Templates (MTEM) United States $0.488B 0.00
Flexion Therapeutics (FLXN) United States $0.483B 0.00
TherapeuticsMD (TXMD) United States $0.476B 0.00
Altimmune (ALT) United States $0.473B 0.00
Akebia Therapeutics (AKBA) United States $0.470B 0.00
Summit Therapeutics (SMMT) United States $0.464B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.464B 10.90
AVITA Medical (RCEL) United States $0.459B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.458B 0.00
Jounce Therapeutics (JNCE) United States $0.441B 0.00
Foghorn Therapeutics (FHTX) United States $0.434B 0.00
DURECT (DRRX) United States $0.407B 0.00
PROFOUND MEDICL (PROF) Canada $0.402B 0.00
Nature's Sunshine Products (NATR) United States $0.402B 19.16
MEI Pharma (MEIP) United States $0.395B 0.00
Acutus Medical (AFIB) United States $0.378B 0.00
Innate Pharma SA (IPHYF) France $0.352B 0.00
Redhill Biopharma (RDHL) Israel $0.342B 0.00
Oncternal Therapeutics (ONCT) United States $0.303B 0.00
Clever Leaves Holdings (CLVR) United States $0.299B 0.00
VYNE Therapeutics (VYNE) United States $0.280B 0.00
Infinity Pharmaceuticals (INFI) United States $0.273B 0.00
Alpine Immune Sciences (ALPN) United States $0.269B 0.00
CASI Pharmaceuticals (CASI) United States $0.253B 0.00
KemPharm (KMPH) United States $0.249B 0.00
Taiwan Liposome (TLC) Taiwan $0.240B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.234B 0.00
Inotiv (NOTV) United States $0.233B 0.00
Xeris Pharmaceuticals (XERS) United States $0.231B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.220B 0.00
Sierra Oncology (SRRA) Canada $0.214B 0.00
Progenity (PROG) United States $0.205B 0.00
Lannett Co Inc (LCI) United States $0.197B 6.63
4D Pharma (LBPS) United Kingdom $0.197B 0.00
OptiNose (OPTN) United States $0.190B 0.00
IMV INC (IMV) Canada $0.189B 0.00
CTI BioPharma (CTIC) United States $0.186B 0.00
Iterum Therapeutics (ITRM) Ireland $0.185B 0.00
Jaguar Animal Health (JAGX) United States $0.183B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.182B 0.00
Novan (NOVN) United States $0.180B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.178B 0.00
Adherex Technologies (FENC) United States $0.167B 0.00
Heat Biologics (HTBX) United States $0.167B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.166B 0.00
Vivos Therapeutics (VVOS) $0.162B 0.00
Calithera Biosciences (CALA) United States $0.161B 0.00
SCYNEXIS (SCYX) United States $0.160B 0.00
Qilian Holding Group (QLI) China $0.154B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.152B 0.00
Champions Oncology (CSBR) United States $0.151B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Onconova Therapeutics (ONTX) United States $0.149B 0.00
Concert Pharmaceuticals (CNCE) United States $0.149B 0.00
MediWound (MDWD) Israel $0.140B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
IsoRay (ISR) United States $0.134B 0.00
Nutriband (NTRB) United States $0.133B 0.00
Aziyo Biologics (AZYO) United States $0.133B 0.00
GlycoMimetics (GLYC) United States $0.131B 0.00
Lipocine (LPCN) United States $0.125B 0.00
Genocea Biosciences (GNCA) United States $0.124B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.115B 0.00
PolarityTE (PTE) United States $0.109B 0.00
Otonomy (OTIC) United States $0.109B 0.00
Natural Alternatives (NAII) United States $0.108B 29.41
Minerva Neurosciences (NERV) United States $0.107B 41.83
Regulus Therapeutics (RGLS) United States $0.102B 0.00
AIM ImmunoTech (AIM) United States $0.101B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.099B 0.00
Assertio Holdings (ASRT) United States $0.092B 0.00
Savara (SVRA) United States $0.091B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.087B 0.00
Recro Pharma (REPH) United States $0.086B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
ProPhase Labs (PRPH) United States $0.078B 0.00
Baudax Bio (BXRX) United States $0.074B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
India Globalization Capital (IGC) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Sigyn Therapeutics (SIGY) United States $0.062B 0.00
Biomerica (BMRA) United States $0.059B 0.00
AgeX Therapeutics (AGE) United States $0.057B 0.00
Brickell Biotech (BBI) United States $0.056B 0.00
IntelGenx Technologies (IGXT) Canada $0.056B 0.00
Inhibikase Therapeutics (IKT) United States $0.054B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.053B 0.00
HANCOCK JAFFE (HJLI) United States $0.050B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 60.80
Viracta Therapeutics (VIRX) United States $0.042B 0.00
Mannatech (MTEX) United States $0.041B 7.20
Can-Fite Biopharma (CANF) Israel $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
RXi Pharmaceuticals (PHIO) United States $0.031B 0.00
Petros Pharmaceuticals (PTPI) United States $0.030B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.028B 0.00
Midatech Pharma (MTP) United Kingdom $0.025B 0.00
JanOne (JAN) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 15.45
SHINECO INC (TYHT) China $0.018B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00